Asset Publisher

< Back to Final Blue Advantage Medical Policies page

Final Policies: K - N

Policy # Policy Title View
BA-253 Laboratory and Genetic Testing for Use of 5-Fluorouracil (5-FU) in Patients with Cancer
BA-322 Laboratory Testing for HIV Tropism
BA-208 Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
BA-728 Laser Interstitial Thermal Therapy (LITT) for Neurological Disorders
BA-009 Light Therapy for Psoriasis
BA-103 Lipid Apheresis
BA-070 Locoregional Therapies for Hepatocellular Carcinoma and Metastatic Liver Carcinoma and Metastatic Carcinoid Tumors of the Liver
BA-270 Low-Level Laser and High-Power Laser Therapies
BA-178 Magnetic Resonance Guided Focused Ultrasound (MRgFUS)
BA-338 Magnetoencephalography-Magnetic Source Imaging
BA-158 Meniscal Allografts and Other Meniscus Implants
BA-512 Microwave Tumor Ablation
BA-460 Mobile Cardiac Outpatient Telemetry and Hybrid Devices
BA-127 Mohs Micrographic Surgery
BA-644 Molecular Testing in the Management of Pulmonary Nodules
BA-124 Myoelectric Prosthetic and Orthotic Components for the Upper Limb
BA-392 Nerve Fiber Density Measurement
BA-635 Noninvasive Fractional Flow Reserve by Coronary Computed Tomographic Angiography
BA-237 Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
BA-166 Nonpharmacologic Treatment of Rosacea